GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senzime AB (OSTO:SEZI) » Definitions » Total Liabilities

Senzime AB (OSTO:SEZI) Total Liabilities : kr56.88 Mil (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Senzime AB Total Liabilities?

Senzime AB's Total Liabilities for the quarter that ended in Mar. 2024 was kr56.88 Mil.

Senzime AB's quarterly Total Liabilities declined from Sep. 2023 (kr58.31 Mil) to Dec. 2023 (kr58.07 Mil) and declined from Dec. 2023 (kr58.07 Mil) to Mar. 2024 (kr56.88 Mil).

Senzime AB's annual Total Liabilities increased from Dec. 2021 (kr24.04 Mil) to Dec. 2022 (kr60.78 Mil) but then declined from Dec. 2022 (kr60.78 Mil) to Dec. 2023 (kr58.07 Mil).


Senzime AB Total Liabilities Historical Data

The historical data trend for Senzime AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senzime AB Total Liabilities Chart

Senzime AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.14 27.55 24.04 60.78 58.07

Senzime AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.52 58.73 58.31 58.07 56.88

Senzime AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Senzime AB's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=23.97+(8.578+21.767
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+3.75)
=58.07

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=433.542-375.477
=58.07

Senzime AB's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=22.635+(8.575+25.666
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=56.88

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=409.849-352.973
=56.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Senzime AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Senzime AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Senzime AB (OSTO:SEZI) Business Description

Traded in Other Exchanges
Address
Ulls vag 41, Uppsala, SWE, 756 51
Senzime AB, a medical technology company, develops, manufactures, and markets patient monitoring systems for monitoring patients. Its solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease healthcare costs. Its product includes TetraGraph and TetraSens, ExSpiron, TetraSens Pediatric, and TetraConnect. Its geographical segments include Sweden, the United States, Europe/Oceania, and Asia.

Senzime AB (OSTO:SEZI) Headlines

No Headlines